Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday.
The Dow traded up 0.88% to 35,742.35 while the NASDAQ fell 0.79% to 14,145.17. The S&P 500 also fell, dropping, 0.15% to 4,543.88.
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 100 points on Thursday.
The Dow traded up 0.85% to 35,729.88 while the NASDAQ fell 0.71% to 14,156.60. The S&P 500 also fell, dropping, 0.13% to 4,544.50.
AbbVie Inc (NYSE: ABBV) has agreed to acquire ImmunoGen Inc (NASDAQ: IMGN) and its flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC) approved f
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.56% to 35,630.09 while the NASDAQ fell 0.11% to 14,242.75. The S&P 500 also rose, gaining, 0.06% to 4,553.49.